How to use this deck

Clinical pharmacology flashcards work best when each card makes you retrieve one decision or relationship, rather than recite a long drug summary. This deck covers foundational pharmacokinetics and common prescribing hazards. It is useful for revision across medical courses, but it is not a substitute for your course syllabus, local formulary or current prescribing guidance.

The deck begins with dose calculations because they connect several core ideas: volume of distribution, clearance, bioavailability and drug concentration. It then moves to monitoring, interactions and safety. For each card, read the question, answer it aloud or in your head, then reveal the answer. Give yourself credit only if you could produce the key fact without a prompt. If you remembered the general idea but missed the clinically important detail, choose a lower grade rather than treating it as mastered.

A MySummaries deck on this topic starts with one card face-up and keeps the remaining cards in the same retrieval queue:

Cards — Clinical Pharmacology — prescribing and pharmacokinetics16 due

What is the loading dose equation?

Loading dose = target plasma concentration × volume of distribution ÷ bioavailability (F). Use consistent units; if F is 1, the drug is given intravenously or has complete bioavailability.

All 16 cards
What is the loading dose equation?Loading dose = target plasma concentration × volume of distribution ÷ bioavailability (F). Use consistent units; if F is 1, the drug is given intravenously or has complete bioavailability.
What determines the maintenance dose rate for a target steady-state concentration?Maintenance dose rate = target steady-state concentration × clearance ÷ bioavailability (F). The maintenance regimen replaces the amount eliminated over time.
What is the equation for elimination half-life in a one-compartment, first-order model?Half-life = 0.693 × volume of distribution ÷ clearance.
Approximately how long does it take to reach steady state with repeated dosing under first-order elimination?About 4–5 half-lives; the time is generally independent of the dose or dosing interval.
Why can a small dose increase cause a disproportionate rise in phenytoin concentration?Phenytoin metabolism can become saturable within the therapeutic range. As metabolic pathways approach capacity, a small dose increase may cause a large concentration increase.
Why can a total phenytoin concentration mislead in a patient with low albumin?Phenytoin is highly protein-bound. Low albumin can increase the unbound, active fraction, so the total concentration may understate active exposure; interpret it with clinical context and appropriate monitoring.
Why does renal impairment increase the risk of aminoglycoside toxicity?Aminoglycosides are cleared mainly by the kidneys. Reduced renal clearance can cause accumulation, increasing nephrotoxicity and ototoxicity risk; dosing and concentration monitoring should follow the applicable protocol.
Which electrolyte abnormality can increase susceptibility to digoxin toxicity?Hypokalaemia increases digoxin binding to the Na⁺/K⁺-ATPase and can increase toxicity risk. Renal impairment can also raise digoxin exposure.
Why can an NSAID, an ACE inhibitor and a diuretic together precipitate acute kidney injury?The combination can reduce glomerular filtration through complementary effects on renal blood flow: the diuretic can reduce circulating volume, the ACE inhibitor dilates the efferent arteriole, and the NSAID reduces prostaglandin-mediated afferent vasodilation.
What is the concern with combining clarithromycin and simvastatin?Clarithromycin inhibits CYP3A4, which metabolises simvastatin. Simvastatin exposure can rise, increasing myopathy and rhabdomyolysis risk; check current interaction guidance and select an appropriate alternative where needed.
What can rifampicin do to the effect of warfarin?Rifampicin induces drug-metabolising enzymes and can reduce warfarin exposure and anticoagulant effect. The interaction needs specialist management and INR monitoring when treatment starts or stops.
Why are ACE inhibitors and angiotensin receptor blockers avoided in pregnancy?They can cause fetal toxicity, particularly affecting fetal renal development. Review and replace them under appropriate clinical guidance when pregnancy is planned or identified.
What is the risk of combining medicines that prolong the QT interval?Their effects can be additive, increasing the risk of QT prolongation and torsades de pointes, especially when other risk factors such as hypokalaemia are present.
How does naloxone reverse opioid toxicity?Naloxone is an opioid receptor antagonist. It displaces opioid agonists from receptors and can reverse respiratory depression; its duration may be shorter than that of the opioid, so recurrence is possible.
What does bioavailability (F) describe?The fraction of an administered dose that reaches systemic circulation unchanged. Intravenous administration has F = 1.
Why is swallowed glyceryl trinitrate not used for rapid relief of angina?Extensive first-pass metabolism in the gut wall and liver limits the amount reaching systemic circulation. Rapid-relief formulations use routes such as sublingual administration to avoid that first pass.

That is a MySummaries deck, filled with clinical pharmacology material. Yours is written from your own notes. Start free

Work through the cards, not just the answers

Start with the first question and retrieve the equation before looking at the answer. For calculation cards, say what each term means and check the units: a loading dose is an amount, whereas a maintenance dose rate is an amount per unit time. Confusing the two is a common way to produce a plausible-looking but incorrect answer.

For the half-life card, connect the equation to the direction of change: a larger volume of distribution lengthens half-life if clearance is unchanged; greater clearance shortens it if volume of distribution is unchanged. The steady-state card tests a separate point. Reaching steady state takes roughly four to five half-lives, not four to five doses. A loading dose can reach a target concentration sooner, but it does not change the drug’s elimination half-life.

The phenytoin cards are a useful pair. First retrieve why dose and concentration may not rise proportionally; then explain why low albumin can make a total concentration a poor guide to active drug. On the monitoring cards, include both the mechanism and the practical consequence: reduced renal clearance can lead to aminoglycoside accumulation, while hypokalaemia can increase susceptibility to digoxin toxicity. Drug concentrations and dose adjustments need to be interpreted with the patient’s clinical state and the relevant local protocol.

For the interaction cards, practise explaining a chain rather than naming two drugs. For example: clarithromycin inhibits CYP3A4; simvastatin exposure can rise; muscle toxicity risk increases. For the NSAID, ACE inhibitor and diuretic combination, identify the different effects on renal perfusion before stating the risk of acute kidney injury. This makes your answer more precise than simply labelling the combination “unsafe”.

When you turn a card, grade your recall honestly. Choose “Again” if you could not retrieve the central fact, “Hard” if you needed substantial effort or missed a key link, “Good” if you recalled it accurately, and “Easy” only if the answer came promptly and completely. The point is not to finish the deck quickly; it is to send uncertain facts back for another retrieval attempt.

The core to keep available

After the first pass, compress the deck into a short checklist. Use it to identify gaps, not as a replacement for testing yourself. The card queue can then return the details you found difficult.

A board on this topic ends up with the core relationships and safety points in one place:

Key pointsClinical Pharmacology — prescribing and pharmacokinetics
Loading dose = target concentration × volume of distribution ÷ bioavailability; maintenance dose rate = target concentration × clearance ÷ bioavailability
For first-order elimination, half-life = 0.693 × volume of distribution ÷ clearance; steady state usually takes about 4–5 half-lives
Renal impairment can cause aminoglycoside accumulation; hypokalaemia increases susceptibility to digoxin toxicity
Clarithromycin can increase simvastatin exposure through CYP3A4 inhibition; rifampicin can reduce warfarin effect through enzyme induction
A compact checklist of the calculations and prescribing risks covered by the deck.

Turn missed marks into another retrieval

A card is not finished when you recognise its answer. Try to reproduce it later without looking, and make the next attempt more specific if you repeatedly miss the same point. For example, replace “the drugs interact” with the complete chain of enzyme effect, altered exposure and clinical risk. For a calculation, write the equation from memory and label the units before substituting values.

If you miss a fact twice, make it a short, answerable prompt rather than copying a paragraph into your notes. A useful remediation card targets the exact missing relationship:

Remediation tray

You lost this mark twice: what is the loading dose equation, and which term accounts for incomplete absorption after a non-intravenous dose?

Add cardDismiss
A focused prompt for retrieving the loading dose equation and the role of bioavailability.

Once you can answer that prompt accurately, test it again in a different form: explain why a loading dose depends on volume of distribution, then distinguish it from the maintenance dose rate, which depends on clearance. That comparison checks whether you understand the variables rather than only remembering a string of symbols.

How MySummaries helps

MySummaries lets you build a revision board from your own pharmacology notes and generate flashcards from it. Use your course material and local prescribing references to check which drugs, monitoring requirements and guidelines belong in your revision, then review the cards that need more retrieval practice.